miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting Bcl-2 and XIAP; microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells. The gene discussed is BCL2; the disease is triple-negative breast carcinoma.